Arcoma AB (STO:ARCOMA)
Sweden
· Delayed Price · Currency is SEK 8.70
+0.30 (3.57%)
May 2, 2025, 4:30 PM CET
Arcoma AB Revenue
In the year 2024, Arcoma AB had annual revenue of 156.81M SEK, down -3.81%. Arcoma AB had revenue of 36.80M in the quarter ending December 31, 2024, a decrease of -28.30%.
Revenue
156.81M
Revenue Growth
-3.81%
P/S Ratio
0.79
Revenue / Employee
4.68M
Employees
31
Market Cap
114.71M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 156.81M | -6.21M | -3.81% |
| Dec 31, 2023 | 163.02M | 37.97M | 30.36% |
| Dec 31, 2022 | 125.05M | 7.92M | 6.76% |
| Dec 31, 2021 | 117.13M | -287.00K | -0.24% |
| Dec 31, 2020 | 117.42M | -16.26M | -12.16% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Swedish Orphan Biovitrum AB | 26.24B |
| Sectra AB | 3.30B |
| Getinge AB | 35.57B |
| Camurus AB | 1.87B |
| Medicover AB | 23.56B |
| AddLife AB | 10.42B |
| Vitrolife AB | 3.61B |
| Bonesupport Holding AB | 997.85M |